Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7XNQ1
|
|||
| Drug Name |
Exeporfinium chloride
|
|||
| Synonyms |
XF-73; 718638-68-7; UNII-1912L54M2V; 1912L54M2V; 3,3'-((porphyrin-5,15-diylbis(4,1-phenylene))bis(oxy))bis(N,N,N-trimethylpropan-1-aminium) chloride; Exeporfinium chloride [INN]; SCHEMBL584418; CHEMBL3822503; XF 73; Q8041945; 3,3'-(21H,23H-Porphyrin-5,15-diylbis(((4,1-phenylene)oxy)-N,N,N-trimethylpropan-1-aminium)) dichloride
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Staphylococcus infection [ICD-11: 1B5Y; ICD-10: A49.0; ICD-9: 001-139] | Phase 2 | [1] | |
| Company |
Destiny Pharma
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C44H50Cl2N6O2
|
|||
| Canonical SMILES |
C[N+](C)(C)CCCOC1=CC=C(C=C1)C2=C3C=CC(=CC4=NC(=C(C5=CC=C(N5)C=C6C=CC2=N6)C7=CC=C(C=C7)OCCC[N+](C)(C)C)C=C4)N3.[Cl-].[Cl-]
|
|||
| InChI |
1S/C44H50N6O2.2ClH/c1-49(2,3)25-7-27-51-37-17-9-31(10-18-37)43-39-21-13-33(45-39)29-35-15-23-41(47-35)44(42-24-16-36(48-42)30-34-14-22-40(43)46-34)32-11-19-38(20-12-32)52-28-8-26-50(4,5)6;;/h9-24,29-30,45,48H,7-8,25-28H2,1-6H3;2*1H/q+2;;/p-2
|
|||
| InChIKey |
KJLHJQGDBJNMPU-UHFFFAOYSA-L
|
|||
| CAS Number |
CAS 718638-68-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03915470) Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.